🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Real-world clinical outcomes and toxicity data will be evaluated in patient...
Status
Unknown
Location
Adamantia Nikolaidi
Start Date
2019-11-01
Trial ID
NCT04724031
Treatments Being Tested
A Phase I of Olaparib with Radiation Therapy in Patients With Inflammatory,...
Status
Completed
Location
Institut Curie
Start Date
2017-07-24
Trial ID
NCT03109080
Treatments Being Tested
The purpose of this study is to see the safety and activity of using pasire...
Status
Completed
Location
Emory University Winship Cancer Institute
Start Date
2011-12
Trial ID
NCT01469572
Treatments Being Tested
This is the first-in-human clinical study of TQB3122, aiming to evaluate th...
Status
Recruiting
Location
Beijing Friendship Hospital, Capital Medical University
Start Date
2026-01-22
Trial ID
NCT07269145
Treatments Being Tested
The overall aim of the trial is to evaluate the safety, tolerability, and p...
Status
Recruiting
Location
City of Hope National Medical Center
Start Date
2020-03-04
Trial ID
NCT04221542
Treatments Being Tested
This is an open-label, multicenter, phase Ib/II study of the combination of...
Status
Terminated
Location
Huntsman Cancer Institute at the University of Utah
Start Date
2022-09-23
Trial ID
NCT05405309
The purpose of this research study is to see how useful it is to look at bi...
Status
Unknown
Location
Princess Margaret Cancer Centre
Start Date
2023-02-23
Trial ID
NCT05065021
Treatments Being Tested
The purpose of this study is to evaluate Sorafenib and local microtherapy g...
Status
Completed
Location
University of Magdeburg
Start Date
2010-12
Trial ID
NCT01126645
Treatments Being Tested
The human epidermal growth factor receptor 2 (HER2) regulates cell growth a...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2019-09-06
Trial ID
NCT03368729
Treatments Being Tested
A number of studies suggest that the combination of PARP inhibitors and ant...
Status
Completed
Location
Sun Yat-sen University Cancer Cetntre
Start Date
2022-09-22
Trial ID
NCT05494580
Treatments Being Tested